Table 7.

Opioid analgesic prescription requirements and outcomes.

Measure	LF	LP	p value
Preoperative CONSORT opioid availability
None	40 (67.8%)	49 (64.5%)	.661*
Short-term or episodic	16 (27.1%)	20 (26.3%)
Long-term	3 (5.1%)	7 (9.2%)
Postoperative CONSORT opioid availability
None	52 (88.1%)	63 (82.9%)	.405*
Short-term or episodic	5 (8.5%)	6 (7.9%)
Long-term	2 (3.4%)	7 (9.2%)
Success†
No	7 (11.9%)	11 (14.5%)	.658*
Yes	52 (88.1%)	65 (85.5%)
Point prevalence‡
3 mo postoperatively	14 (23.7%)	13 (17.1%)	.340*
1 year postoperatively	5 (8.5%)	8 (10.5%)	.689*
Maximum prescribed daily dose (MME/day)
Preoperative, median and IQR	44 (23–60)	30 (20–52)	.068§
Postoperative, median and IQR	23 (17–40)	30 (19–57)	1.000§
Opioid prescriptions at Discharge
Total prescription MME, median and IQR	900 (60–1,350)	900 (450–1337)	.899§
Total days supplied, median and IQR	9 (5–15)	8 (5–15)	.289§

CONSORT, Consortium to Study Opioid Risks and Trends; MME, Morphine Milligram Equivalents; IQR, Interquartile Range.

^⁎Chi-square test.

^†Defined as either achieving an improved CONSORT opioid availability classification postoperatively compared to preoperatively, or maintaining a status of no opioid use.

^‡The prevalence of opioid availability between 83-97 and 358-372 days after discharge, respectively.

^§Wilcoxon rank sum test.